Discover your unique microbiome profile with advanced testing

Learn More →
Oligosaccharides

Galactooligosaccharides (GOS)

Prebiotic oligosaccharides structurally similar to human milk sugars that strongly promote Bifidobacterium growth, especially beneficial for infants and adults alike.

Oligosaccharides
Prebiotic type
4
Food sources
2
Target bacteria

Food Sources

Naturally found in these foods:

Human breast milk (naturally) Commercial synthesis from lactose Legumes Some vegetables

Key Benefits

  • Strong bifidogenic effect
  • Supports infant gut development
  • Improves calcium absorption
  • May reduce anxiety symptoms
  • Enhances immune function

Bacteria This Prebiotic Feeds

This prebiotic selectively nourishes these beneficial microorganisms:

Bifidobacterium View details →
Lactobacillus View details →

Overview

Galactooligosaccharides (GOS) are prebiotic oligosaccharides composed of galactose units with a terminal glucose molecule[1]. Structurally similar to the oligosaccharides found naturally in human breast milk, GOS are among the most effective prebiotics for promoting Bifidobacterium growth. They are commercially produced through enzymatic transgalactosylation of lactose and have been extensively studied in both infant and adult populations.

Structure and Production

GOS are produced through the action of β-galactosidase enzymes on lactose[2]:

Structural Features

  • Chain length: 2-8 galactose units (typically 2-5)
  • Terminal glucose unit
  • Various glycosidic linkages (β-1,4; β-1,6; β-1,3)
  • Degree of polymerization affects fermentation rate

Commercial Production

  • Enzymatic conversion of lactose using β-galactosidase
  • Multiple enzyme sources (bacterial, fungal, yeast)
  • Resulting mixtures contain various GOS species
  • Product characteristics vary by enzyme source and conditions

Mechanism of Action

Prebiotic Effect

GOS exert their prebiotic effects through selective utilization by beneficial bacteria[1]:

  1. Selective fermentation: Bifidobacteria possess β-galactosidase enzymes that efficiently cleave GOS bonds
  2. Competitive advantage: Beneficial bacteria gain nutritional advantage over pathogens
  3. SCFA production: Fermentation produces acetate, propionate, and lactate
  4. pH reduction: Acidification of colonic environment inhibits pathogen growth

Anti-Adhesion Effects

Research has demonstrated that GOS can prevent pathogenic bacteria from adhering to intestinal cells[4]:

  • GOS act as receptor mimics
  • Block pathogen binding sites
  • Reduce enteropathogenic E. coli adherence
  • May protect against enteric infections

Structural Similarity to HMOs

GOS's structural resemblance to human milk oligosaccharides (HMOs) underlies their effectiveness in infant nutrition[6]:

  • Both promote Bifidobacterium infantis
  • Similar receptor-blocking properties
  • Support developing gut microbiome
  • Enhance immune system maturation

Effects on Gut Microbiome

Primary Effects

  • Bifidobacterium: Strongest bifidogenic effect among common prebiotics
  • Lactobacillus: Consistent enhancement of lactobacilli populations
  • Bacteroides: Variable effects depending on GOS type and dose

Age-Specific Effects

Infants: GOS supplementation in infant formula has been shown to[6]:

  • Shift microbiota toward breast-fed infant profile
  • Increase Bifidobacterium dominance
  • Reduce potential pathogens
  • Improve stool consistency

Adults: In elderly individuals, GOS supplementation demonstrated[5]:

  • Significant increases in Bifidobacterium species
  • Enhanced immune parameters
  • Improved metabolomic profiles
  • Modulation of inflammatory markers

Clinical Evidence

Gut Health

GOS supplementation consistently shows:

  • Increased stool frequency in constipated individuals
  • Improved stool consistency
  • Reduced symptoms of functional gastrointestinal disorders
  • Enhanced mineral absorption (particularly calcium)

Immune Function

Studies in elderly populations have demonstrated GOS's immunomodulatory effects[5]:

  • Increased phagocytic activity
  • Enhanced NK cell activity
  • Reduced pro-inflammatory cytokines
  • Improved anti-inflammatory markers

Mental Health and Gut-Brain Axis

A notable study found that GOS supplementation influences stress responses and emotional processing[3]:

  • Reduced cortisol awakening response: Lower morning cortisol levels
  • Altered emotional bias: Decreased attention to negative stimuli
  • Gut-brain connection: Supports the role of prebiotics in mental well-being
  • Potential anxiolytic effects: May benefit individuals with anxiety

Infant Nutrition

Extensive evidence supports GOS in infant formulas[6]:

  • Closer microbiota composition to breastfed infants
  • Reduced incidence of infections
  • Softer stool consistency
  • Potential protection against allergies

Dosage and Usage

Recommended Dosages

Population Dose Evidence Level
Adults 2.5-10g daily Strong
Elderly 5.5g daily Strong
Infants (formula) 0.8g/100ml Strong
Children 2.5-5g daily Moderate

Practical Considerations

  • Start gradually: Begin with 2.5g and increase over 1-2 weeks
  • Timing: Can be taken with or without food
  • Combination: Often combined with FOS in synbiotic products
  • Duration: Effects observed within 1-2 weeks

GOS in Infant Formula

The addition of GOS to infant formulas has become standard practice[6]:

Benefits

  • Mimics breast milk prebiotic effects
  • Supports immune development
  • Promotes healthy gut colonization
  • Reduces formula-related constipation

Formulation

  • Often combined with long-chain FOS (9:1 ratio)
  • Dosage typically 0.8g/100ml formula
  • Extensively studied for safety in infants
  • Approved for use in infant formulas worldwide

Comparison with Other Prebiotics

Feature GOS FOS Inulin
Bifidogenic potency Very high High High
Fermentation rate Fast-moderate Fast Moderate
HMO similarity High Moderate Low
Infant formula use Common Common Less common
Tolerance Good Good Good

Safety and Tolerability

GOS are generally well-tolerated[2]:

  • May cause mild flatulence at higher doses
  • Contains trace lactose (consideration for severe lactose intolerance)
  • No significant adverse effects in clinical trials
  • Safe for long-term use in all age groups
  • Approved for infant formula use by regulatory authorities

Special Considerations

Lactose Content

While GOS are produced from lactose, the final product contains minimal residual lactose:

  • Most lactose intolerant individuals tolerate GOS well
  • Severely lactose intolerant individuals should start with low doses
  • Lactose-free GOS products are available

Synbiotic Applications

GOS are commonly combined with probiotics (synbiotics):

  • Enhanced Bifidobacterium survival
  • Synergistic effects on gut health
  • Common in commercial probiotic products

Summary

Galactooligosaccharides represent one of the most potent and well-studied prebiotics, with particularly strong evidence for promoting Bifidobacterium growth. Their structural similarity to human milk oligosaccharides makes them uniquely valuable for infant nutrition, while their demonstrated effects on immune function, gut-brain axis, and metabolic health extend their benefits to adults and elderly populations. With excellent tolerability and extensive safety data, GOS are a foundational prebiotic for supporting gut microbiome health across the lifespan.

Dosage Guidelines

Recommended Dosage

2.5-10g daily

Start with a lower dose and gradually increase to minimize digestive discomfort. Consult a healthcare provider for personalized recommendations.

References

  1. Davani-Davari D, Negahdaripour M, Karimzadeh I, et al.. Prebiotics: Definition, Types, Sources, Mechanisms, and Clinical Applications. Foods. 2019;8(3):92. doi:10.3390/foods8030092
  2. Torres DPM, Gonçalves MDPF, Teixeira JA, Rodrigues LR. Galacto-Oligosaccharides: Production, Properties, Applications, and Significance as Prebiotics. Comprehensive Reviews in Food Science and Food Safety. 2017;16(5):1034-1054. doi:10.1111/1541-4337.12290
  3. Schmidt K, Cowen PJ, Harmer CJ, et al.. Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers. Psychopharmacology. 2015;232:1793-1801. doi:10.1007/s00213-014-3810-0
  4. Shoaf K, Mulvey GL, Armstrong GD, Hutkins RW. Prebiotic galactooligosaccharides reduce adherence of enteropathogenic Escherichia coli to tissue culture cells. Infection and Immunity. 2006;74(12):6920-6928. doi:10.1128/IAI.01030-06
  5. Vulevic J, Juric A, Walton GE, et al.. Influence of galacto-oligosaccharide mixture (B-GOS) on gut microbiota, immune parameters and metabolomics in elderly persons. British Journal of Nutrition. 2015;114(4):586-595. doi:10.1017/S0007114515001889
  6. Vandenplas Y, Zakharova I, Dmitrieva Y. Oligosaccharides in infant formula: more evidence to validate the role of prebiotics. British Journal of Nutrition. 2015;113(9):1339-1344. doi:10.1017/S0007114515000823